Advances in cardioprotective strategies: Bridging traditional pharmacotherapy and regenerative medicine
Cardiovascular diseases (CVDs) remain the leading global cause of death and disability, underscoring the need for improved therapies. Key emerging strategies include pharmacological cardioprotection, cell-based therapies and the use of exosomes as therapeutic agents and biomarkers. Aim of this study...
Saved in:
| Main Authors: | Hladkykh Fedir V., Matvieienko Mariia M., Liadova Tetiana I, Karafulidi Olha V., Komorovsky Roman R. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2025-01-01
|
| Series: | Scripta Medica |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2025/2490-33292503521H.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Beta-Blockers as a First-Line Treatment for Primary Hypertension
by: Maryam Izadi, et al.
Published: (2024-10-01) -
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024-11-01) -
Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease
by: Andrew K. Evans, et al.
Published: (2024-12-01) -
A clinical continuum of aquagenic pruritus, aquadynia, and aquagenic urticaria responsive to β-blockers
by: Evelien M. Hutten, MD, et al.
Published: (2025-05-01) -
Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers
by: V. N. Larina, et al.
Published: (2021-11-01)